These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7730020)

  • 1. Aged mice fail to upregulate ICAM-1 after Pseudomonas aeruginosa corneal infection.
    Hobden JA; Masinick SA; Barrett RP; Hazlett LD
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1107-14. PubMed ID: 7730020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intercellular adhesion molecule-2 (ICAM-2) and Pseudomonas aeruginosa ocular infection.
    Hobden JA
    DNA Cell Biol; 2003 Oct; 22(10):649-55. PubMed ID: 14611686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation.
    Kernacki KA; Barrett R; Hazlett LD
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3168-76. PubMed ID: 10586939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of IL-12 and IFN-gamma in Pseudomonas aeruginosa corneal infection.
    Hazlett LD; Rudner XL; McClellan SA; Barrett RP; Lighvani S
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):419-24. PubMed ID: 11818386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection.
    Hazlett LD; McClellan SA; Barrett RP; Liu J; Zhang Y; Lighvani S
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):797-807. PubMed ID: 17251480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.
    Hazlett LD; McClellan S; Kwon B; Barrett R
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):805-10. PubMed ID: 10711697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis.
    Twining SS; Zhou X; Schulte DP; Wilson PM; Fish B; Moulder J
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):511-22. PubMed ID: 8595951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nona-D-arginine therapy for Pseudomonas aeruginosa keratitis.
    Karicherla P; Hobden JA
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):256-62. PubMed ID: 18775859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of arachidonic acid metabolism and the polymorphonuclear leukocyte response in mice infected intracorneally with Pseudomonas aeruginosa.
    Kernacki KA; Berk RS
    Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):16-23. PubMed ID: 7822143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice.
    Hobden JA; Masinick SA; Barrett RP; Hazlett LD
    Infect Immun; 1997 Jul; 65(7):2754-8. PubMed ID: 9199446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further studies on the role of IL-12 in Pseudomonas aeruginosa corneal infection.
    Hazlett LD; Huang X; McClellan SA; Barrett RP
    Eye (Lond); 2003 Nov; 17(8):863-71. PubMed ID: 14631390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging and PMN response to P. aeruginosa infection.
    Kernacki KA; Barrett RP; McClellan SA; Hazlett LD
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3019-25. PubMed ID: 10967059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lecithin-bound superoxide dismutase in the prevention of neutrophil-induced damage of corneal tissue.
    Matsumoto K; Shimmura S; Goto E; Saito K; Takeuchi T; Miyajima S; Negi A; Tsubota K
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):30-5. PubMed ID: 9430542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Pseudomonas aeruginosa corneal infection in IL-1 beta converting enzyme (ICE, caspase-1) deficient mice.
    Thakur A; Barrett RP; McClellan S; Hazlett LD
    Curr Eye Res; 2004; 29(4-5):225-33. PubMed ID: 15590467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIMP-1 role in protection against Pseudomonas aeruginosa-induced corneal destruction.
    Kernacki KA; Chunta JL; Barrett RP; Hazlett LD
    Exp Eye Res; 2004 Jun; 78(6):1155-62. PubMed ID: 15109922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early TIMP gene expression after corneal infection with Pseudomonas aeruginosa.
    Kernacki KA; Goebel DJ; Poosch MS; Hazlett LD
    Invest Ophthalmol Vis Sci; 1998 Feb; 39(2):331-5. PubMed ID: 9477990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different strains of Pseudomonas aeruginosa isolated from ocular infections or inflammation display distinct corneal pathologies in an animal model.
    Cole N; Willcox MD; Fleiszig SM; Stapleton F; Bao B; Tout S; Husband A
    Curr Eye Res; 1998 Jul; 17(7):730-5. PubMed ID: 9678419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of intercellular adhesion molecule-1 in mice with Pseudomonas-induced pyelonephritis.
    Yokoo A; Hirose T; Matsukawa M; Hotta H; Kunishima Y; Takahashi S
    J Urol; 1998 Aug; 160(2):592-6. PubMed ID: 9679934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The implications of the upregulation of ICAM-1/VCAM-1 expression of corneal fibroblasts on the pathogenesis of allergic keratopathy.
    Okada N; Fukagawa K; Takano Y; Dogru M; Tsubota K; Fujishima H; Matsumoto K; Nakajima T; Saito H
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4512-8. PubMed ID: 16303942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.